The Board of Regents of The University of Texas System
发明人:
BOOTHMAN, DAVID,GAO, JINMING,BEY, ERIK,DONG, YING
申请号:
PL11827555
公开号:
PL2619331T3
申请日:
2011.09.22
申请国别(地区):
PL
年份:
2018
代理人:
摘要:
Disclosed herein are methods for determining whether an individual with cancer is suitable for a treatment with an NQO1 bioactivatable drug, predicting responsiveness of an individual with cancer to a treatment with an NQO1 bioactivatable drug, and treating an individual with cancer with an NQO1 bioactivatable drug composition.